Table 5.
All hematological malignancies | Lymphoid malignancies | Myeloid malignancies and AL | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
# | ERR/100 mGy | 95% CI | # | ERR/100 mGy | 95% CI | # | ERR/100 mGy | 95% CI | ||||
Main results | 790 | 1.96 | 1.10 | 3.12 | 578 | 2.01 | 1.02 | 3.42 | 203 | 2.02 | 0.47 | 4.77 |
ABM doses | ||||||||||||
Doses lagged by 1 year | 790 | 1.99 | 1.13 | 3.16 | 578 | 2.04 | 1.05 | 3.47 | 203 | 2.07 | 0.54 | 4.80 |
Doses lagged by 5 years | 790 | 1.06 | 0.45 | 1.82 | 578 | 1.25 | 0.53 | 2.20 | 203 | 0.60 | −0.43 | 2.20 |
Use of median of dose realizations instead of mean | 790 | 2.08 | 1.09 | 3.42 | 578 | 2.13 | 0.99 | 3.75 | 203 | 2.17 | 0.36 | 5.35 |
Analyses restricted to individuals with cumulative doses up to: | ||||||||||||
99th percentile | 777 | 3.17 | 1.90 | 4.91 | 567 | 3.02 | 1.59 | 5.09 | 201 | 3.81 | 1.43 | 8.20 |
98th percentile | 761 | 3.54 | 2.08 | 5.55 | 554 | 3.27 | 1.66 | 5.63 | 198 | 4.43 | 1.67 | 9.62 |
95th percentile | 710 | 2.80 | 1.27 | 4.94 | 520 | 2.79 | 1.02 | 5.41 | 181 | 2.88 | 0.34 | 7.75 |
Exclusions | ||||||||||||
5 years from first CT | 524 | 2.36 | 1.21 | 4.05 | 381 | 2.54 | 1.19 | 4.66 | 139 | 1.74 | 0.05 | 5.25 |
10 years from first CT | 261 | 2.67 | 1.02 | 5.69 | 185 | 3.12 | 1.13 | 7.08 | 72 | 1.28 | -0.62 | 8.11 |
Individuals born before the start of cancer registration | 490 | 1.54 | 0.68 | 2.80 | 365 | 1.59 | 0.60 | 3.14 | 119 | 1.84 | 0.20 | 5.29 |
Hospitals with low reporting consistency | 603 | 1.93 | 0.97 | 3.29 | 440 | 2.17 | 1.00 | 3.93 | 158 | 1.49 | 0.00 | 4.31 |
Follow-up 2 years after country-specific maximum age at exposure | 491 | 1.27 | 0.49 | 2.39 | 356 | 1.26 | 0.39 | 2.63 | 128 | 1.61 | 0.11 | 6.61 |
Individuals with no vital status | 739 | 1.73 | 0.89 | 2.97 | 541 | 1.91 | 0.91 | 3.35 | 189 | 1.39 | 0.03 | 3.85 |
United Kingdom—main results | NA | 276 | 2.77 | 1.12 | 5.55 | NA | ||||||
Excluding individuals who underwent transplant | NA | 256 | 2.57 | 0.97 | 5.31 | NA |
#, number of hematological malignancies cases; NA, not applicable.